![Dan Zhang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dan Zhang
Chief Executive Officer at ClinChoice Medical (TIANJIN) Co., Ltd.
Dan Zhang active positions
Companies | Position | Start | End |
---|---|---|---|
ClinChoice Medical (TIANJIN) Co., Ltd.
![]() ClinChoice Medical (TIANJIN) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services ClinChoice Medical (TIANJIN) Co., Ltd. operates as a contract research organization. It offers consulting, project management, clinical operations, data reporting and laboratory services. The firm also provides good clinical practice compliant clinical research services for multinational clients. The company was founded by Young Wang, Kaijun Li, Dan Zhang and Joanne Jiang Chen in October 2006 and is headquartered in Beijing, the Republic of China. | Chief Executive Officer | 01/10/2006 | - |
Chairman | 01/10/2006 | - | |
Founder | 01/10/2006 | - | |
President | 01/10/2006 | - | |
Fountain Medical Development Ltd.
![]() Fountain Medical Development Ltd. BiotechnologyHealth Technology Part of ClinChoice Medical (TIANJIN) Co., Ltd., Fountain Medical Development Ltd. is a clinical CRO that provides one-stop services for biomedical and medical equipment customers. Clinchoice has been accelerating drug and device approvals to market for more than 25 years and offers services such as project management, clinical operations, biological statistics, data management, registered affairs, medical affairs, and drug warning. The quality service runs through every link of the Clinchoice Kunyu service, and the quality assurance team is an independent team that focuses on the construction and continuous improvement of the American company's internal quality management system. The company was founded by Dan Zhang and Ling Zhen has been the CEO of the company since 2020. Laibiyi was founded in 2016 and is committed to solving the pain points of clinical research through in-depth cooperation with hospitals and a clinical research center that builds standardized standards. In 2021, Clinchoice Kunzhe acquired Laibiyi Technology (Xiamen) Co., Ltd. to further improve its phase I clinical trial platform. | Chairman | - | - |
Founder | - | - |
Career history of Dan Zhang
Statistics
International
China | 3 |
Operational
Founder | 2 |
Chairman | 2 |
Chief Executive Officer | 1 |
Sectoral
Commercial Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
ClinChoice Medical (TIANJIN) Co., Ltd.
![]() ClinChoice Medical (TIANJIN) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services ClinChoice Medical (TIANJIN) Co., Ltd. operates as a contract research organization. It offers consulting, project management, clinical operations, data reporting and laboratory services. The firm also provides good clinical practice compliant clinical research services for multinational clients. The company was founded by Young Wang, Kaijun Li, Dan Zhang and Joanne Jiang Chen in October 2006 and is headquartered in Beijing, the Republic of China. | Commercial Services |
Fountain Medical Development Ltd.
![]() Fountain Medical Development Ltd. BiotechnologyHealth Technology Part of ClinChoice Medical (TIANJIN) Co., Ltd., Fountain Medical Development Ltd. is a clinical CRO that provides one-stop services for biomedical and medical equipment customers. Clinchoice has been accelerating drug and device approvals to market for more than 25 years and offers services such as project management, clinical operations, biological statistics, data management, registered affairs, medical affairs, and drug warning. The quality service runs through every link of the Clinchoice Kunyu service, and the quality assurance team is an independent team that focuses on the construction and continuous improvement of the American company's internal quality management system. The company was founded by Dan Zhang and Ling Zhen has been the CEO of the company since 2020. Laibiyi was founded in 2016 and is committed to solving the pain points of clinical research through in-depth cooperation with hospitals and a clinical research center that builds standardized standards. In 2021, Clinchoice Kunzhe acquired Laibiyi Technology (Xiamen) Co., Ltd. to further improve its phase I clinical trial platform. | Health Technology |
- Stock Market
- Insiders
- Dan Zhang
- Experience